{
    "2019-03-06": [
        [
            {
                "time": "",
                "original_text": "智飞生物子公司诺如病毒疫苗临床申请获受理 或将解决世界性预防难题",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "诺如病毒疫苗",
                        "临床申请",
                        "受理",
                        "世界性预防难题"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "智飞生物：四价重组诺如病毒疫苗临床申请获受理",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "四价重组诺如病毒疫苗",
                        "临床申请",
                        "受理"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}